Table 3 Demographic and clinical characteristics of the patients with a positive SeptiFast test
All patients (n=94) | Patients with Cp >17.5 (n=72) | Patients with Cp <17.5 (n=22) | P-value for comparison | |
|---|---|---|---|---|
Female | 35 (37%) | 26 (36%) | 9 (41%) | 0.80 |
Age, years | 74 (14-96) | 69 (25-96) | 74 (14-93) | 0.36 |
Co-morbidities | ||||
Heart disease | 22 (23%) | 14 (20%) | 8 (36%) | 0.12 |
Neurological disease | 13 (14%) | 8 (11%) | 5 (23%) | 0.18 |
Chronic renal failure | 12 (13%) | 10 (14%) | 2 (9%) | 0.54 |
Neoplasms | 17 (18%) | 14 (20%) | 3 (14%) | 0.50 |
Clinical data | ||||
Antibiotics before analyses | 20 (21%) | 15 (21%) | 5 (23%) | 0.85 |
Blood culture positivity | 45 (48%) | 23 (32%) | 22 (100%) | <0.001 |
C-reactive protein | 108 (1-446) | 93 (1-372) | 212 (12-446) | 0.002 |
Body temperature, C° | 38.7 (37.0-41.4) | 38.7 (37.1-41.0) | 38.8 (37.0-41.4) | 0.89 |
> 2 SIRS criteria | 82 (87%) | 61 (85%) | 21 (96%) | 0.19 |
Severe sepsis/septic shock | 27 (29%) | 11(15%) | 16 (73%) | <0.001 |
Septic shock | 3 (3%) | 0 | 3 (14%) | 0.01 |
Hospitalisation length, days | 7 (0-78) | 5 (0-75) | 19.5 (4-78) | <0.001 |
Intensive care unit admission | 8 (9%) | 3 (4%) | 5 (23%) | 0.016 |
1 month mortality rate | 8 (9%) | 4 (6%) | 4 (18%) | 0.084 |